Amélie Marsot

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Venues

British journal of clinical pharmacology

Antibiotics (Basel, Switzerland)

Pediatric pulmonology

Journal of clinical pharmacy and therapeutics

Université de Montréal

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université de Montréal Jul 03 2018

Canada

Professeur Adjoint :: Pharmacie

Publications

Alexandre Duong, Ahmed El Gamal, Véronique Bilodeau, Justine Huot, Carole Delorme, Johanne Poudrette, Benoît Crevier, Amélie Marsot
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population. Pharmacotherapy (2024)
Alexandre Duong, Ahmed El Gamal, Véronique Bilodeau, Justine Huot, Carole Delorme, Johanne Poudrette, Benoît Crevier, Amélie Marsot
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population. Pharmacotherapy 44 (6) (2024)
Romain Guilhaumou, Constance Chevrier, Jean Loup Setti, Elisabeth Jouve, Amélie Marsot, Nathan Julian, Olivier Blin, Pierre Simeone, David Lagier, Djamel Mokart, Nicolas Bruder, Marc Garnier, Lionel Velly
β -Lactam Pharmacokinetic/Pharmacodynamic Target Attainment in Intensive Care Unit Patients: A Prospective, Observational, Cohort Study. Antibiotics (Basel, Switzerland) 12 (8) (2023)
Ibrahim El-Haffaf, Romain Guilhaumou, Lionel Velly, Amélie Marsot
Impact of Piperacillin Unbound Fraction Variability on Dosing Recommendations in Critically Ill Patients. British journal of clinical pharmacology (2022)
Alexandre Duong, Chantale Simard, David R Williamson, Amélie Marsot
Model Re-Estimation: An Alternative for Poor Predictive Performance during External Evaluations? Example of Gentamicin in Critically Ill Patients. Pharmaceutics 14 (7) (2022)
Caren Jabamikos, Yi Tong Fang, Kim-Dan Nguyen, Alice Sananikone, Kym Archambault, Emily Bing, Miguel Chagnon, Omar Husainalamoodi, Amélie Marsot, Marc-Alexandre Duceppe, Marc M Perreault
Validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system for augmented renal clearance prediction in a trauma subgroup of a mixed ICU population. Journal of clinical pharmacy and therapeutics 47 (10) (2022)
Véronique Bilodeau, Justine Huot, Catherine Perreault, Louis-Patrick Haraoui, Carole Delorme, Johanne Poudrette, Amélie Marsot, Benoît Crevier
VANCOmycin dose adjustments comparing trough levels to the ratio of the area under de curve to the minimum inhibitory concentration method using a BAYESian approach: A feasibility study. Journal of clinical pharmacy and therapeutics (2022)
Mehdi El Hassani, Chantale Simard, Sylvie Pilote, Isabelle Cloutier, Sara Soufsaf, Amélie Marsot
Consideration of height-based tobramycin dosing regimens for the treatment of adult cystic fibrosis pulmonary exacerbations. British journal of clinical pharmacology (2021)
Alexandre Duong, Chantale Simard, Yi Le Wang, David Williamson, Amélie Marsot
Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling? Antibiotics (Basel, Switzerland) 10 (5) (2021)
Amélie Marsot, Amélie Ménard, Julien Dupouey, Laurent Allanioux, Olivier Blin, Romain Guilhaumou
Evaluation of current dosing guidance for oral rifampicin treatment in adult patients with osteoarticular infections. British journal of clinical pharmacology 86 (11) (2020)
Daniel J G Thirion, Valérian Pasche, Elias Matouk, Amélie Marsot
Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic model. Pediatric pulmonology 55 (5) (2020)
Y L Wang, R Guilhaumou, O Blin, L Velly, Amélie Marsot
External evaluation of population pharmacokinetic models for continuous administration of meropenem in critically ill adult patients. European journal of clinical pharmacology 76 (9) (2020)
Daniel J G Thirion, Valérian Pasche, Amélie Marsot
What is the recommended amikacin dosing for cystic fibrosis patients with acute pulmonary exacerbations? Pediatric pulmonology 54 (11) (2019)
Amélie Marsot, F Gallais, C Galambrun, C Coze, O Blin, N Andre, R Guilhaumou
Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens. Paediatric drugs 20 (4) (2019)
Amélie Marsot, Fabrice Michel, Estelle Chasseloup, Olivier Paut, Romain Guilhaumou, Olivier Blin
Phenobarbital in intensive care unit pediatric population: predictive performances of population pharmacokinetic model. Fundamental & clinical pharmacology 31 (5) (2017)
Amélie Marsot, Romain Guilhaumou, Camille Riff, Olivier Blin
Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies. Clinical pharmacokinetics 56 (2) (2017)

Amélie Marsot.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amélie Marsot